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Abstract 
Background: Premenstrual syndrome (PMS) is among the most unfavorable 
problems in women in reproductive age; however its pathophysiology is still not 
fully confirmed. Vitamin D as an immunomodulator could prevent inflammatory 
state before and during menstruation.  
Objective: The aim was to investigate whether there is any relationship between 
serum vitamin D levels and PMS. 
Materials and Methods: In total, 82 women participate in this case-control study 
which was conducted in Shahid Akbar-abadi hospital from November 2013 to 
March 2015. Categorization was based on an Iranian version of the premenstrual 
symptoms screening tool (PSST). Levels of 25 hydroxy-vitamin D3 (25OHD) were 
determined by using 25-OH Vitamin D ELISA kit in luteal phase. Characteristics of 
participants and vitamin D levels were compared between two groups by using 
independent sample t-test. 
Results: Menarche age of women with PMS was significantly lower than normal 
women (p=0.04). Body mass index was not statistically different between groups. 
We observed a high rate of vitamin D deficiency and also its severe deficiency in 
both PMS and non-PMS groups. However, our study demonstrated no significant 
difference in the levels of serum 25OHD between the two groups. 
Conclusion: It seems there is no association between PMS and serum levels of 
vitamin D3; however, the high rate of vitamin D deficiency among young Iranian 
women emerges special health care considerations in this group. 
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Introduction 
 
remenstrual syndrome (PMS) is 
among the most unfavorable 
problems in women with 
reproductive age; which imposes a great deal 
of economic burden to the society. Although 
many hypotheses have been proposed for its 
pathophysiology, none are still fully confirmed. 
The effects of progesterone and Gamma 
Amino Butyric Acid (GABA) in the symptom 
creation have been established; however, 
definitive treatment for this syndrome is not 
well known up to now (1). 
One of the hormones which were proposed 
to have a preventive role in PMS is vitamin D3 
(2). Previous data support the idea that 
vitamin D3 could lower the risk of PMS; 
however, the mechanisms which underlie 
these desirable effects are not fully 
understood (3). Vitamin D as an 
immunomodulator could prevent inflammatory 
state before and during menstruation and also 
could alter neurotransmitters’ function (4, 5). 
This study was performed to assess the 
possibility of relationship between PMS and 
serum levels of 25 hydroxy-vitamin D3 
(25OHD) in luteal phase of young women in 
reproductive age, during the zenith of irritating 
symptoms. 
 
Materials and methods 
 
In this cross sectional, case-control study, 
82 women were selected among the 18-45 
years old women who referred for routine 
gynecologic investigation to a gynecologic 
clinic from November 2013 to March 2015 in a 
university affiliated hospital, Tehran, Iran. The 
study was approved by the ethics institutional 
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review board of Tehran University of Medical 
Sciences. The study was granted by 
Research Deputy, Tehran University of 
Medical Sciences. . The aim and procedure of 
the study was described for these referrers by 
a gynecologist. Women who signed informed 
consent participated in the study.  
Diagnosis of premenstrual syndrome was 
based on an Iranian version of premenstrual 
symptoms screening tool (PSST) (6). 
According to this tool we designed a 
questionnaire and used it for diagnosis of 
PMS. A part of consisted questionnaire was 
related to general health and gynecologic 
status of the participants. All participants 
completed the questionnaire and according to 
their responses, they were categorized to one 
of two groups; PMS or control. As the number 
of premenstrual dysphoric disorder (PMDD) 
cases was low, they were categorized in PMS 
group. 
Exclusion criteria were any contained 
endocrine disorders (thyroid dysfunction, 
polycystic ovary syndrome, menstrual cycle 
disturbances, diabetes mellitus), history of 
previous documented gynecologic disorders, 
history of previous documented autoimmune 
diseases, and any consumption of these 
medications: oral contraceptive agents, 
vitamin D supplements, corticosteroids and 
anti-depressant drugs within 6 months of the 
study. 
Five mm blood samples were taken from 
each person in the luteal phase according to 
their reported last menstrual period. Serums 
were separated and stored at -20°C until all 
samples were collected. Levels of 25OHD 
were determined by using 25-OH Vitamin D 
ELISA kit (Euroimmun, Luebeck, Germany) 
according to manufacturer’s instructions. The 
reference ranges of plasma 25OHD were 
mentioned as follows: very severe vitamin D 
deficiency; <5 ng/ml, severe vitamin D 
deficiency; 5-10 ng/ml, vitamin D deficiency; 
10-20 ng/ml, suboptimal vitamin D provision; 
20-30 ng/ml, optimal vitamin D level; 30-50 
ng/ml, upper normal; 50-70 ng/ml, overdose 
but not toxic; 70-150 ng/ml and vitamin D 
intoxication; as >150 ng/ml. 
 
Statistical analysis 
For data analysis, SPSS software Version 
16 was used (SPSS, Inc. Chicago, IL, USA). 
After confirming the normality of data 
distribution with Kolmogorov-Smirnov test, we 
use independent sample t-test for comparing 
the levels of 25OH vit D3 between two groups. 
P<0.05 were considered statistically 
significant. For drawing the figures, GraphPad 
software Version 5 was used (GraphPad 
software inc. La Jolla, CA, USA). 
 
Results 
 
Eighty two women participated in this study 
and completed the questionnaire. Nine cases 
were excluded from the study according to the 
exclusion criteria. Basic variables of the two 
study groups are demonstrated in table I. 
The results demonstrate that the majority of 
PMS patients (87.5%) and normal women 
(84.4%) were vitamin D deficient. Vitamin D 
levels in the PMS group were as follows: 
17.1% very severe deficiency, 39.0% severe 
deficiency, 31.7% deficiency, 2.4% 
suboptimal, 4.9% optimal and 4.9% with upper 
normal levels. In the control (non-PMS) group 
the levels were as follows: 31.1% very severe 
deficiency, 28.1% severe deficiency, 25.0% 
deficiency, 3.1% suboptimal, 9.4% optimal 
and 3.1% with upper normal levels. 
The difference of mean serum 25OHD level 
was not statistically significant between 
groups as shown in figure 1 (13.74±2.24 in 
PMS vs. 12.67±2.25 ng/mL in control). Also 
there was no significant difference in the 
severity of 25OHD deficiency between groups. 
We also found no meaningful relationship 
between the severity of vitamin D level 
deficiency and the severity of PMS symptoms. 
 
 
Table I. Basic variables of the two study groups of participants 
Groups PMS Control p-value 
Number 41 32 - 
Age (years)  28.46 ± 4.31  31.25 ± 7.39 0.64 
Menarche age (years)  12.65 ± 1.46 13.37 ± 1.47 0.04 
Body mass index  22.72 ± 2.89 23.93 ± 2.57 0.12 
Data presented as (Mean ± SD)  PMS: Premenstrual syndrome 
Vitamin D and Premenstrual Syndrome 
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Figure 1. Serum levels of Vitamin D in the two study groups  
 
Discussion 
 
Basic variables’ findings indicated that only 
menarche age is statistically different between 
PMS and normal women; however, our study 
demonstrated no different levels of 25OHD 
between groups. Study results showed that 
menarche age of women with PMS is 
significantly lower than normal women. Unlike 
this finding, Bertone-Johnson et al and Thys- 
Jacob et al showed that there is no difference 
in menarche age between premenstrual 
syndrome or premenstrual dysphoric disease 
and normal women (3, 7). Lower menarche 
age is associated with many health problems, 
which could involve premenstrual syndrome 
(8). 
Our findings suggest that body mass index 
is not statistically different between two 
groups. Although some studies show a direct 
linear relation between two parameters, there 
are studies that do not show this relationship 
(3, 7, 9, 10). This investigation demonstrated 
that the levels of 25OHD were not different 
between PMS patients compared to control 
group. In concordance with our results 
Obeidat et al indicated that there is not any 
association between 25OHD levels and 
premenstrual symptoms among Jordanian 
females (11). Similarly Bertone-Johnson et al 
in their prospective cohort study explained 
that 25OHD levels were not related to the risk 
of PMS and higher vitamin D levels could 
improve some symptoms related to PMS, but 
not all of them (12). 
Our study could not show any association 
between 25OHD level in luteal phase and 
persistence of PMS. One possible explanation 
for this could be the high prevalence of 
vitamin D deficiency among both our case and 
control groups. Several studies showed the 
high prevalence of vitamin D deficiency in 
different parts of Iran (13-15). We studied the 
young women in the city of Tehran. Heshmat 
and colleagues studied the prevalence of 
vitamin D deficiency in five major cities of Iran 
and demonstrated that the prevalence of this 
deficiency is more evident in Tehran, the 
capital city of Iran (16). Vitamin D deficiency is 
very common in Iran and other countries in 
Middle East and this could be partly related to 
limited sun exposure due to cultural practices, 
poor vitamin D supplementation and calcium 
deficiency in this region (17). 
As the main limitation of this study, the high 
prevalence of vitamin D deficiency in Iran and 
many other countries in Middle East makes it 
hard to find a significant relationship between 
25OHD deficiency and other pathologies such 
as PMS and PMDD. Another concept is that 
there is still no universal agreement about 
normal levels of vitamin D and its deficiency 
states. Moradzadeh and colleagues in their 
study of 5329 blood samples from different 
areas of Iran, calculated different cut-off 
values for definition of vitamin D deficiency 
states among Iranian population (18). 
However, they also found unexpectedly high 
prevalence of all stages of vitamin D 
deficiency among both Iranian women 
(75.1%) and men (72.1%). Vitamin D is a 
secosteroid hormone with known calcium 
regulatory effects. Also, it shows anti- 
proliferative, pro-differentiative and 
immunomodulatory properties (19). Although 
the main source of vitamin D is skin 
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biosynthesis, a part of which is supported by 
diet. Vitamin D deficiency is prevalent 
worldwide and it includes Iranian reproductive 
age women (20). 
Although our study could not show different 
levels of vitamin D between PMS and normal 
women, since PMS is associated with 
increased inflammatory cytokines, anti- 
inflammatory metabolites such as vitamin D 
could be able to improve some symptoms of 
PMS (4). The high rate of vitamin D deficiency 
among young Iranian women emerges special 
health care considerations in this group. 
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